Medical Care
Global HER2 Tumor Marker Testing Market Research Report 2025
- May 12, 25
- ID: 235438
- Pages: 89
- Figures: 84
- Views: 31
The global market for HER2 Tumor Marker Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
HER2 Tumor Marker Testing is a diagnostic test used in oncology to assess the status of the HER2 gene and the presence of HER2 protein receptors in breast cancer and some other types of cancer, such as gastric (stomach) cancer. HER2 stands for Human Epidermal Growth Factor Receptor 2, which is a gene that encodes a protein receptor on the surface of certain cells, including breast cells. HER2 status is an important factor in determining treatment options and predicting the prognosis for individuals with specific types of cancer.
The global market for HER2 Tumor Marker Testing has been experiencing steady growth. This growth is primarily driven by the increasing incidence of breast cancer and the importance of HER2 status in determining treatment decisions. The market size is influenced by factors such as population aging, awareness of breast cancer screening, and advancements in diagnostic techniques. North America, particularly the United States, is a significant market for HER2 Tumor Marker Testing. The region has well-established breast cancer screening and diagnosis programs. The adoption of targeted therapies, such as Herceptin, has been prominent in this region. Europe also has a substantial market for HER2 testing, with countries like the United Kingdom, Germany, and France being key contributors. The European market is characterized by a growing emphasis on early cancer detection and personalized medicine. The Asia-Pacific region, including countries like China and India, offers growth opportunities. The increasing healthcare spending, growing awareness of breast cancer, and rising population contribute to market expansion.
This report aims to provide a comprehensive presentation of the global market for HER2 Tumor Marker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 Tumor Marker Testing.
The HER2 Tumor Marker Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HER2 Tumor Marker Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HER2 Tumor Marker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Roche
Thermo Fisher Scientific
Agilent
Leica Biosystems
Biocare Medical
BioGenex
Sysmex
Abnova
Novartis
InvivoGen
Segment by Type
Immunohistochemistry (IHC)
Fluorescence In Situ Hybridization (FISH)
Silver In Situ Hybridization (SISH)
Others
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HER2 Tumor Marker Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
HER2 Tumor Marker Testing is a diagnostic test used in oncology to assess the status of the HER2 gene and the presence of HER2 protein receptors in breast cancer and some other types of cancer, such as gastric (stomach) cancer. HER2 stands for Human Epidermal Growth Factor Receptor 2, which is a gene that encodes a protein receptor on the surface of certain cells, including breast cells. HER2 status is an important factor in determining treatment options and predicting the prognosis for individuals with specific types of cancer.
The global market for HER2 Tumor Marker Testing has been experiencing steady growth. This growth is primarily driven by the increasing incidence of breast cancer and the importance of HER2 status in determining treatment decisions. The market size is influenced by factors such as population aging, awareness of breast cancer screening, and advancements in diagnostic techniques. North America, particularly the United States, is a significant market for HER2 Tumor Marker Testing. The region has well-established breast cancer screening and diagnosis programs. The adoption of targeted therapies, such as Herceptin, has been prominent in this region. Europe also has a substantial market for HER2 testing, with countries like the United Kingdom, Germany, and France being key contributors. The European market is characterized by a growing emphasis on early cancer detection and personalized medicine. The Asia-Pacific region, including countries like China and India, offers growth opportunities. The increasing healthcare spending, growing awareness of breast cancer, and rising population contribute to market expansion.
This report aims to provide a comprehensive presentation of the global market for HER2 Tumor Marker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 Tumor Marker Testing.
The HER2 Tumor Marker Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HER2 Tumor Marker Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HER2 Tumor Marker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Roche
Thermo Fisher Scientific
Agilent
Leica Biosystems
Biocare Medical
BioGenex
Sysmex
Abnova
Novartis
InvivoGen
Segment by Type
Immunohistochemistry (IHC)
Fluorescence In Situ Hybridization (FISH)
Silver In Situ Hybridization (SISH)
Others
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HER2 Tumor Marker Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 Tumor Marker Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunohistochemistry (IHC)
1.2.3 Fluorescence In Situ Hybridization (FISH)
1.2.4 Silver In Situ Hybridization (SISH)
1.2.5 Others
1.3 Market by Application
1.3.1 Global HER2 Tumor Marker Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HER2 Tumor Marker Testing Market Perspective (2020-2031)
2.2 Global HER2 Tumor Marker Testing Growth Trends by Region
2.2.1 Global HER2 Tumor Marker Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 HER2 Tumor Marker Testing Historic Market Size by Region (2020-2025)
2.2.3 HER2 Tumor Marker Testing Forecasted Market Size by Region (2026-2031)
2.3 HER2 Tumor Marker Testing Market Dynamics
2.3.1 HER2 Tumor Marker Testing Industry Trends
2.3.2 HER2 Tumor Marker Testing Market Drivers
2.3.3 HER2 Tumor Marker Testing Market Challenges
2.3.4 HER2 Tumor Marker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HER2 Tumor Marker Testing Players by Revenue
3.1.1 Global Top HER2 Tumor Marker Testing Players by Revenue (2020-2025)
3.1.2 Global HER2 Tumor Marker Testing Revenue Market Share by Players (2020-2025)
3.2 Global HER2 Tumor Marker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by HER2 Tumor Marker Testing Revenue
3.4 Global HER2 Tumor Marker Testing Market Concentration Ratio
3.4.1 Global HER2 Tumor Marker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 Tumor Marker Testing Revenue in 2024
3.5 Global Key Players of HER2 Tumor Marker Testing Head office and Area Served
3.6 Global Key Players of HER2 Tumor Marker Testing, Product and Application
3.7 Global Key Players of HER2 Tumor Marker Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 Tumor Marker Testing Breakdown Data by Type
4.1 Global HER2 Tumor Marker Testing Historic Market Size by Type (2020-2025)
4.2 Global HER2 Tumor Marker Testing Forecasted Market Size by Type (2026-2031)
5 HER2 Tumor Marker Testing Breakdown Data by Application
5.1 Global HER2 Tumor Marker Testing Historic Market Size by Application (2020-2025)
5.2 Global HER2 Tumor Marker Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America HER2 Tumor Marker Testing Market Size (2020-2031)
6.2 North America HER2 Tumor Marker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America HER2 Tumor Marker Testing Market Size by Country (2020-2025)
6.4 North America HER2 Tumor Marker Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HER2 Tumor Marker Testing Market Size (2020-2031)
7.2 Europe HER2 Tumor Marker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe HER2 Tumor Marker Testing Market Size by Country (2020-2025)
7.4 Europe HER2 Tumor Marker Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HER2 Tumor Marker Testing Market Size (2020-2031)
8.2 Asia-Pacific HER2 Tumor Marker Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific HER2 Tumor Marker Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific HER2 Tumor Marker Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HER2 Tumor Marker Testing Market Size (2020-2031)
9.2 Latin America HER2 Tumor Marker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America HER2 Tumor Marker Testing Market Size by Country (2020-2025)
9.4 Latin America HER2 Tumor Marker Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HER2 Tumor Marker Testing Market Size (2020-2031)
10.2 Middle East & Africa HER2 Tumor Marker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa HER2 Tumor Marker Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa HER2 Tumor Marker Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott HER2 Tumor Marker Testing Introduction
11.1.4 Abbott Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche HER2 Tumor Marker Testing Introduction
11.2.4 Roche Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific HER2 Tumor Marker Testing Introduction
11.3.4 Thermo Fisher Scientific Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Agilent
11.4.1 Agilent Company Details
11.4.2 Agilent Business Overview
11.4.3 Agilent HER2 Tumor Marker Testing Introduction
11.4.4 Agilent Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.4.5 Agilent Recent Development
11.5 Leica Biosystems
11.5.1 Leica Biosystems Company Details
11.5.2 Leica Biosystems Business Overview
11.5.3 Leica Biosystems HER2 Tumor Marker Testing Introduction
11.5.4 Leica Biosystems Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.5.5 Leica Biosystems Recent Development
11.6 Biocare Medical
11.6.1 Biocare Medical Company Details
11.6.2 Biocare Medical Business Overview
11.6.3 Biocare Medical HER2 Tumor Marker Testing Introduction
11.6.4 Biocare Medical Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.6.5 Biocare Medical Recent Development
11.7 BioGenex
11.7.1 BioGenex Company Details
11.7.2 BioGenex Business Overview
11.7.3 BioGenex HER2 Tumor Marker Testing Introduction
11.7.4 BioGenex Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.7.5 BioGenex Recent Development
11.8 Sysmex
11.8.1 Sysmex Company Details
11.8.2 Sysmex Business Overview
11.8.3 Sysmex HER2 Tumor Marker Testing Introduction
11.8.4 Sysmex Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.8.5 Sysmex Recent Development
11.9 Abnova
11.9.1 Abnova Company Details
11.9.2 Abnova Business Overview
11.9.3 Abnova HER2 Tumor Marker Testing Introduction
11.9.4 Abnova Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.9.5 Abnova Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis HER2 Tumor Marker Testing Introduction
11.10.4 Novartis Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.10.5 Novartis Recent Development
11.11 InvivoGen
11.11.1 InvivoGen Company Details
11.11.2 InvivoGen Business Overview
11.11.3 InvivoGen HER2 Tumor Marker Testing Introduction
11.11.4 InvivoGen Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.11.5 InvivoGen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 Tumor Marker Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunohistochemistry (IHC)
1.2.3 Fluorescence In Situ Hybridization (FISH)
1.2.4 Silver In Situ Hybridization (SISH)
1.2.5 Others
1.3 Market by Application
1.3.1 Global HER2 Tumor Marker Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HER2 Tumor Marker Testing Market Perspective (2020-2031)
2.2 Global HER2 Tumor Marker Testing Growth Trends by Region
2.2.1 Global HER2 Tumor Marker Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 HER2 Tumor Marker Testing Historic Market Size by Region (2020-2025)
2.2.3 HER2 Tumor Marker Testing Forecasted Market Size by Region (2026-2031)
2.3 HER2 Tumor Marker Testing Market Dynamics
2.3.1 HER2 Tumor Marker Testing Industry Trends
2.3.2 HER2 Tumor Marker Testing Market Drivers
2.3.3 HER2 Tumor Marker Testing Market Challenges
2.3.4 HER2 Tumor Marker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HER2 Tumor Marker Testing Players by Revenue
3.1.1 Global Top HER2 Tumor Marker Testing Players by Revenue (2020-2025)
3.1.2 Global HER2 Tumor Marker Testing Revenue Market Share by Players (2020-2025)
3.2 Global HER2 Tumor Marker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by HER2 Tumor Marker Testing Revenue
3.4 Global HER2 Tumor Marker Testing Market Concentration Ratio
3.4.1 Global HER2 Tumor Marker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 Tumor Marker Testing Revenue in 2024
3.5 Global Key Players of HER2 Tumor Marker Testing Head office and Area Served
3.6 Global Key Players of HER2 Tumor Marker Testing, Product and Application
3.7 Global Key Players of HER2 Tumor Marker Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 Tumor Marker Testing Breakdown Data by Type
4.1 Global HER2 Tumor Marker Testing Historic Market Size by Type (2020-2025)
4.2 Global HER2 Tumor Marker Testing Forecasted Market Size by Type (2026-2031)
5 HER2 Tumor Marker Testing Breakdown Data by Application
5.1 Global HER2 Tumor Marker Testing Historic Market Size by Application (2020-2025)
5.2 Global HER2 Tumor Marker Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America HER2 Tumor Marker Testing Market Size (2020-2031)
6.2 North America HER2 Tumor Marker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America HER2 Tumor Marker Testing Market Size by Country (2020-2025)
6.4 North America HER2 Tumor Marker Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HER2 Tumor Marker Testing Market Size (2020-2031)
7.2 Europe HER2 Tumor Marker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe HER2 Tumor Marker Testing Market Size by Country (2020-2025)
7.4 Europe HER2 Tumor Marker Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HER2 Tumor Marker Testing Market Size (2020-2031)
8.2 Asia-Pacific HER2 Tumor Marker Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific HER2 Tumor Marker Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific HER2 Tumor Marker Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HER2 Tumor Marker Testing Market Size (2020-2031)
9.2 Latin America HER2 Tumor Marker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America HER2 Tumor Marker Testing Market Size by Country (2020-2025)
9.4 Latin America HER2 Tumor Marker Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HER2 Tumor Marker Testing Market Size (2020-2031)
10.2 Middle East & Africa HER2 Tumor Marker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa HER2 Tumor Marker Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa HER2 Tumor Marker Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott HER2 Tumor Marker Testing Introduction
11.1.4 Abbott Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche HER2 Tumor Marker Testing Introduction
11.2.4 Roche Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific HER2 Tumor Marker Testing Introduction
11.3.4 Thermo Fisher Scientific Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Agilent
11.4.1 Agilent Company Details
11.4.2 Agilent Business Overview
11.4.3 Agilent HER2 Tumor Marker Testing Introduction
11.4.4 Agilent Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.4.5 Agilent Recent Development
11.5 Leica Biosystems
11.5.1 Leica Biosystems Company Details
11.5.2 Leica Biosystems Business Overview
11.5.3 Leica Biosystems HER2 Tumor Marker Testing Introduction
11.5.4 Leica Biosystems Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.5.5 Leica Biosystems Recent Development
11.6 Biocare Medical
11.6.1 Biocare Medical Company Details
11.6.2 Biocare Medical Business Overview
11.6.3 Biocare Medical HER2 Tumor Marker Testing Introduction
11.6.4 Biocare Medical Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.6.5 Biocare Medical Recent Development
11.7 BioGenex
11.7.1 BioGenex Company Details
11.7.2 BioGenex Business Overview
11.7.3 BioGenex HER2 Tumor Marker Testing Introduction
11.7.4 BioGenex Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.7.5 BioGenex Recent Development
11.8 Sysmex
11.8.1 Sysmex Company Details
11.8.2 Sysmex Business Overview
11.8.3 Sysmex HER2 Tumor Marker Testing Introduction
11.8.4 Sysmex Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.8.5 Sysmex Recent Development
11.9 Abnova
11.9.1 Abnova Company Details
11.9.2 Abnova Business Overview
11.9.3 Abnova HER2 Tumor Marker Testing Introduction
11.9.4 Abnova Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.9.5 Abnova Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis HER2 Tumor Marker Testing Introduction
11.10.4 Novartis Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.10.5 Novartis Recent Development
11.11 InvivoGen
11.11.1 InvivoGen Company Details
11.11.2 InvivoGen Business Overview
11.11.3 InvivoGen HER2 Tumor Marker Testing Introduction
11.11.4 InvivoGen Revenue in HER2 Tumor Marker Testing Business (2020-2025)
11.11.5 InvivoGen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global HER2 Tumor Marker Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunohistochemistry (IHC)
Table 3. Key Players of Fluorescence In Situ Hybridization (FISH)
Table 4. Key Players of Silver In Situ Hybridization (SISH)
Table 5. Key Players of Others
Table 6. Global HER2 Tumor Marker Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global HER2 Tumor Marker Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global HER2 Tumor Marker Testing Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global HER2 Tumor Marker Testing Market Share by Region (2020-2025)
Table 10. Global HER2 Tumor Marker Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global HER2 Tumor Marker Testing Market Share by Region (2026-2031)
Table 12. HER2 Tumor Marker Testing Market Trends
Table 13. HER2 Tumor Marker Testing Market Drivers
Table 14. HER2 Tumor Marker Testing Market Challenges
Table 15. HER2 Tumor Marker Testing Market Restraints
Table 16. Global HER2 Tumor Marker Testing Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global HER2 Tumor Marker Testing Market Share by Players (2020-2025)
Table 18. Global Top HER2 Tumor Marker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Tumor Marker Testing as of 2024)
Table 19. Ranking of Global Top HER2 Tumor Marker Testing Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by HER2 Tumor Marker Testing Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of HER2 Tumor Marker Testing, Headquarters and Area Served
Table 22. Global Key Players of HER2 Tumor Marker Testing, Product and Application
Table 23. Global Key Players of HER2 Tumor Marker Testing, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global HER2 Tumor Marker Testing Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global HER2 Tumor Marker Testing Revenue Market Share by Type (2020-2025)
Table 27. Global HER2 Tumor Marker Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global HER2 Tumor Marker Testing Revenue Market Share by Type (2026-2031)
Table 29. Global HER2 Tumor Marker Testing Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global HER2 Tumor Marker Testing Revenue Market Share by Application (2020-2025)
Table 31. Global HER2 Tumor Marker Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global HER2 Tumor Marker Testing Revenue Market Share by Application (2026-2031)
Table 33. North America HER2 Tumor Marker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America HER2 Tumor Marker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America HER2 Tumor Marker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe HER2 Tumor Marker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe HER2 Tumor Marker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe HER2 Tumor Marker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific HER2 Tumor Marker Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific HER2 Tumor Marker Testing Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific HER2 Tumor Marker Testing Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America HER2 Tumor Marker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America HER2 Tumor Marker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America HER2 Tumor Marker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa HER2 Tumor Marker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa HER2 Tumor Marker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa HER2 Tumor Marker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Company Details
Table 49. Abbott Business Overview
Table 50. Abbott HER2 Tumor Marker Testing Product
Table 51. Abbott Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Roche Company Details
Table 54. Roche Business Overview
Table 55. Roche HER2 Tumor Marker Testing Product
Table 56. Roche Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Thermo Fisher Scientific Company Details
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific HER2 Tumor Marker Testing Product
Table 61. Thermo Fisher Scientific Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 62. Thermo Fisher Scientific Recent Development
Table 63. Agilent Company Details
Table 64. Agilent Business Overview
Table 65. Agilent HER2 Tumor Marker Testing Product
Table 66. Agilent Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 67. Agilent Recent Development
Table 68. Leica Biosystems Company Details
Table 69. Leica Biosystems Business Overview
Table 70. Leica Biosystems HER2 Tumor Marker Testing Product
Table 71. Leica Biosystems Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 72. Leica Biosystems Recent Development
Table 73. Biocare Medical Company Details
Table 74. Biocare Medical Business Overview
Table 75. Biocare Medical HER2 Tumor Marker Testing Product
Table 76. Biocare Medical Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 77. Biocare Medical Recent Development
Table 78. BioGenex Company Details
Table 79. BioGenex Business Overview
Table 80. BioGenex HER2 Tumor Marker Testing Product
Table 81. BioGenex Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 82. BioGenex Recent Development
Table 83. Sysmex Company Details
Table 84. Sysmex Business Overview
Table 85. Sysmex HER2 Tumor Marker Testing Product
Table 86. Sysmex Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 87. Sysmex Recent Development
Table 88. Abnova Company Details
Table 89. Abnova Business Overview
Table 90. Abnova HER2 Tumor Marker Testing Product
Table 91. Abnova Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 92. Abnova Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis HER2 Tumor Marker Testing Product
Table 96. Novartis Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. InvivoGen Company Details
Table 99. InvivoGen Business Overview
Table 100. InvivoGen HER2 Tumor Marker Testing Product
Table 101. InvivoGen Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 102. InvivoGen Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. HER2 Tumor Marker Testing Picture
Figure 2. Global HER2 Tumor Marker Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global HER2 Tumor Marker Testing Market Share by Type: 2024 VS 2031
Figure 4. Immunohistochemistry (IHC) Features
Figure 5. Fluorescence In Situ Hybridization (FISH) Features
Figure 6. Silver In Situ Hybridization (SISH) Features
Figure 7. Others Features
Figure 8. Global HER2 Tumor Marker Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global HER2 Tumor Marker Testing Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. HER2 Tumor Marker Testing Report Years Considered
Figure 14. Global HER2 Tumor Marker Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global HER2 Tumor Marker Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global HER2 Tumor Marker Testing Market Share by Region: 2024 VS 2031
Figure 17. Global HER2 Tumor Marker Testing Market Share by Players in 2024
Figure 18. Global Top HER2 Tumor Marker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Tumor Marker Testing as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by HER2 Tumor Marker Testing Revenue in 2024
Figure 20. North America HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America HER2 Tumor Marker Testing Market Share by Country (2020-2031)
Figure 22. United States HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe HER2 Tumor Marker Testing Market Share by Country (2020-2031)
Figure 26. Germany HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific HER2 Tumor Marker Testing Market Share by Region (2020-2031)
Figure 34. China HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America HER2 Tumor Marker Testing Market Share by Country (2020-2031)
Figure 42. Mexico HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa HER2 Tumor Marker Testing Market Share by Country (2020-2031)
Figure 46. Turkey HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 50. Roche Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 52. Agilent Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 53. Leica Biosystems Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 54. Biocare Medical Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 55. BioGenex Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 56. Sysmex Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 57. Abnova Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 58. Novartis Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 59. InvivoGen Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global HER2 Tumor Marker Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunohistochemistry (IHC)
Table 3. Key Players of Fluorescence In Situ Hybridization (FISH)
Table 4. Key Players of Silver In Situ Hybridization (SISH)
Table 5. Key Players of Others
Table 6. Global HER2 Tumor Marker Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global HER2 Tumor Marker Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global HER2 Tumor Marker Testing Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global HER2 Tumor Marker Testing Market Share by Region (2020-2025)
Table 10. Global HER2 Tumor Marker Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global HER2 Tumor Marker Testing Market Share by Region (2026-2031)
Table 12. HER2 Tumor Marker Testing Market Trends
Table 13. HER2 Tumor Marker Testing Market Drivers
Table 14. HER2 Tumor Marker Testing Market Challenges
Table 15. HER2 Tumor Marker Testing Market Restraints
Table 16. Global HER2 Tumor Marker Testing Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global HER2 Tumor Marker Testing Market Share by Players (2020-2025)
Table 18. Global Top HER2 Tumor Marker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Tumor Marker Testing as of 2024)
Table 19. Ranking of Global Top HER2 Tumor Marker Testing Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by HER2 Tumor Marker Testing Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of HER2 Tumor Marker Testing, Headquarters and Area Served
Table 22. Global Key Players of HER2 Tumor Marker Testing, Product and Application
Table 23. Global Key Players of HER2 Tumor Marker Testing, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global HER2 Tumor Marker Testing Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global HER2 Tumor Marker Testing Revenue Market Share by Type (2020-2025)
Table 27. Global HER2 Tumor Marker Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global HER2 Tumor Marker Testing Revenue Market Share by Type (2026-2031)
Table 29. Global HER2 Tumor Marker Testing Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global HER2 Tumor Marker Testing Revenue Market Share by Application (2020-2025)
Table 31. Global HER2 Tumor Marker Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global HER2 Tumor Marker Testing Revenue Market Share by Application (2026-2031)
Table 33. North America HER2 Tumor Marker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America HER2 Tumor Marker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America HER2 Tumor Marker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe HER2 Tumor Marker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe HER2 Tumor Marker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe HER2 Tumor Marker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific HER2 Tumor Marker Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific HER2 Tumor Marker Testing Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific HER2 Tumor Marker Testing Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America HER2 Tumor Marker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America HER2 Tumor Marker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America HER2 Tumor Marker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa HER2 Tumor Marker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa HER2 Tumor Marker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa HER2 Tumor Marker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Company Details
Table 49. Abbott Business Overview
Table 50. Abbott HER2 Tumor Marker Testing Product
Table 51. Abbott Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Roche Company Details
Table 54. Roche Business Overview
Table 55. Roche HER2 Tumor Marker Testing Product
Table 56. Roche Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Thermo Fisher Scientific Company Details
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific HER2 Tumor Marker Testing Product
Table 61. Thermo Fisher Scientific Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 62. Thermo Fisher Scientific Recent Development
Table 63. Agilent Company Details
Table 64. Agilent Business Overview
Table 65. Agilent HER2 Tumor Marker Testing Product
Table 66. Agilent Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 67. Agilent Recent Development
Table 68. Leica Biosystems Company Details
Table 69. Leica Biosystems Business Overview
Table 70. Leica Biosystems HER2 Tumor Marker Testing Product
Table 71. Leica Biosystems Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 72. Leica Biosystems Recent Development
Table 73. Biocare Medical Company Details
Table 74. Biocare Medical Business Overview
Table 75. Biocare Medical HER2 Tumor Marker Testing Product
Table 76. Biocare Medical Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 77. Biocare Medical Recent Development
Table 78. BioGenex Company Details
Table 79. BioGenex Business Overview
Table 80. BioGenex HER2 Tumor Marker Testing Product
Table 81. BioGenex Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 82. BioGenex Recent Development
Table 83. Sysmex Company Details
Table 84. Sysmex Business Overview
Table 85. Sysmex HER2 Tumor Marker Testing Product
Table 86. Sysmex Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 87. Sysmex Recent Development
Table 88. Abnova Company Details
Table 89. Abnova Business Overview
Table 90. Abnova HER2 Tumor Marker Testing Product
Table 91. Abnova Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 92. Abnova Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis HER2 Tumor Marker Testing Product
Table 96. Novartis Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. InvivoGen Company Details
Table 99. InvivoGen Business Overview
Table 100. InvivoGen HER2 Tumor Marker Testing Product
Table 101. InvivoGen Revenue in HER2 Tumor Marker Testing Business (2020-2025) & (US$ Million)
Table 102. InvivoGen Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. HER2 Tumor Marker Testing Picture
Figure 2. Global HER2 Tumor Marker Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global HER2 Tumor Marker Testing Market Share by Type: 2024 VS 2031
Figure 4. Immunohistochemistry (IHC) Features
Figure 5. Fluorescence In Situ Hybridization (FISH) Features
Figure 6. Silver In Situ Hybridization (SISH) Features
Figure 7. Others Features
Figure 8. Global HER2 Tumor Marker Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global HER2 Tumor Marker Testing Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. HER2 Tumor Marker Testing Report Years Considered
Figure 14. Global HER2 Tumor Marker Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global HER2 Tumor Marker Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global HER2 Tumor Marker Testing Market Share by Region: 2024 VS 2031
Figure 17. Global HER2 Tumor Marker Testing Market Share by Players in 2024
Figure 18. Global Top HER2 Tumor Marker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Tumor Marker Testing as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by HER2 Tumor Marker Testing Revenue in 2024
Figure 20. North America HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America HER2 Tumor Marker Testing Market Share by Country (2020-2031)
Figure 22. United States HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe HER2 Tumor Marker Testing Market Share by Country (2020-2031)
Figure 26. Germany HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific HER2 Tumor Marker Testing Market Share by Region (2020-2031)
Figure 34. China HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America HER2 Tumor Marker Testing Market Share by Country (2020-2031)
Figure 42. Mexico HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa HER2 Tumor Marker Testing Market Share by Country (2020-2031)
Figure 46. Turkey HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE HER2 Tumor Marker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 50. Roche Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 52. Agilent Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 53. Leica Biosystems Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 54. Biocare Medical Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 55. BioGenex Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 56. Sysmex Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 57. Abnova Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 58. Novartis Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 59. InvivoGen Revenue Growth Rate in HER2 Tumor Marker Testing Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232